Richard Chin, Chief Executive Officer at Kindred Biosciences, Inc. (KIN), sold 40,000 shares at $10.57 ($423K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $423k KIN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |
| KIN | SELL | 2018-11-02 | $587K | — | Filing → |